Literature DB >> 13319011

Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood.

G A MAYER, W F CONNELL.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; CARDIOVASCULAR DISEASES/blood in; COUMARIN/derivatives; PROTHROMBIN TIME/effect of drugs on

Mesh：

Substances：

Year:  1956        PMID： 13319011     DOI： 10.1001/jama.1956.02970090032007

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  9 in total

1.  The present status of anticoagulant therapy in coronary disease.

Authors:  W F CONNELL
Journal:  Can Med Assoc J       Date:  1957-04-15       Impact factor: 8.262

2.  Experience with outpatient anticoagulant therapy.

Authors:  W G GRANT; R L MACMILLAN
Journal:  Can Med Assoc J       Date:  1958-03-01       Impact factor: 8.262

3.  The anticoagulant effect of a new coumarin derivative-sintrom (geigy)- and its control by standardized clotting time.

Authors:  W F CONNELL; G A MAYER
Journal:  Can Med Assoc J       Date:  1957-02-15       Impact factor: 8.262

4.  A clinical assessment of anticoagulant control.

Authors:  L N ROBERTS; G P MASON
Journal:  Can Med Assoc J       Date:  1961-10-07       Impact factor: 8.262

5.  SEVERE HYPOPROTHROMBINAEMIA AFTER PROPYLTHIOURACIL THERAPY.

Authors:  G D'Angelo; L P Le Gresley
Journal:  Can Med Assoc J       Date:  1959-09-15       Impact factor: 8.262

6.  Evaluation of anticoagulant therapy with anisindione (miradon).

Authors:  W F CONNELL; G A MAYER
Journal:  Can Med Assoc J       Date:  1959-05-15       Impact factor: 8.262

7.  AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.

Authors:  C W BAUGH
Journal:  Can Med Assoc J       Date:  1965-01-16       Impact factor: 8.262

8.  Control of ethyl biscoumacetate (tromexan) therapy by standardized clotting time of whole blood.

Authors:  G A MAYER; W F CONNELL
Journal:  Can Med Assoc J       Date:  1957-11-15       Impact factor: 8.262

9.  Structure-Activity Analysis and Molecular Docking Studies of Coumarins from Toddalia asiatica as Multifunctional Agents for Alzheimer's Disease.

Authors:  Pitchayakarn Takomthong; Pornthip Waiwut; Chavi Yenjai; Bungon Sripanidkulchai; Prasert Reubroycharoen; Ren Lai; Peter Kamau; Chantana Boonyarat
Journal:  Biomedicines       Date:  2020-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.